Corona Remedies Profile
Key Indicators
- Authorised Capital ₹ 61.17 Cr
as on 19-11-2024
- Paid Up Capital ₹ 61.16 Cr
as on 19-11-2024
- Company Age 20 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 250.00 Cr
as on 19-11-2024
- Satisfied Charges ₹ 112.58 Cr
as on 19-11-2024
- Revenue 7.37%
(FY 2022)
- Profit -100.57%
(FY 2022)
- Ebitda -83.09%
(FY 2022)
- Net Worth -5.01%
(FY 2022)
- Total Assets -3.81%
(FY 2022)
About Corona Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 61.17 Cr and a paid-up capital of Rs 61.16 Cr.
The company currently has active open charges totaling ₹250.00 Cr. The company has closed loans amounting to ₹112.58 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Corona Remedies Private Limited India are Niravkumar Mehta as Ceo, Bhavin Bhagat as Cfo, and Bhagya Dave as Company Secretary. Monica Kanuga, Viral Sitwala, Ankur Mehta, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24231GJ2004PTC044656
- Company No.
044656
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Aug 2004
- Date of AGM
19 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Corona Remedies Private Limited offer?
Corona Remedies Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Antidiabetic Medicine, TB, Tumor & Cancer Drugs, Anti Cancer Injection, Anti Cancer Medicines, Diabetes Medicine, Common Disease Medicines, Pharmaceutical Tablets, Brain & Nervous System Drugs, Antiepileptic Drugs.
Who are the key members and board of directors at Corona Remedies?
Executive Team (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Niravkumar Mehta | CEO | 04-Sep-2024 | Current |
| Bhavin Bhagat | CFO | 29-Oct-2024 | Current |
| Bhagya Dave | Company Secretary | Current | |
Ankur Mehta  | Managing Director | 27-Aug-2004 | Current |
| Nirav Mehta | Managing Director | 30-May-2007 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kshitij Sheth | Nominee Director | 30-Mar-2021 | Current |
| Ameetkumar Desai | Director | 22-Nov-2022 | Current |
| Monica Kanuga | Director | 29-Oct-2024 | Current |
| Viral Sitwala | Whole-Time Director | 01-Jan-2010 | Current |
| Kirtikumar Mehta | Director | 27-Aug-2004 | Current |
Financial Performance and Corporate Structure Insights of Corona Remedies.
Corona Remedies Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 7.37% increase. The company also saw a substantial fall in profitability, with a 100.57% decrease in profit. The company's net worth dipped by a decrease of 5.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Corona Remedies?
In 2024, Corona Remedies had a promoter holding of 72.50% and a public holding of 27.50%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jm Financial Asset Reconstruction Company LimitedActive 17 years 3 monthsAmeetkumar Desai is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Dec 2023 | ₹50.00 Cr | Open |
Citi Bank N.A. Creation Date: 07 Jul 2023 | ₹200.00 Cr | Open |
Others Creation Date: 28 Aug 2019 | ₹3.28 M | Satisfied |
How Many Employees Work at Corona Remedies?
Corona Remedies has a workforce of 4223 employees as of Nov 19, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Corona Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Corona Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
